In a multicenter retrospective study by Soria et al., which included 732 UTUC patients after RNU, 35.8% of patients had overexpression of HER2, which was associated with SBCa [35]. This evidence concerns the gene ERBB2 and renal pelvis/ureter urothelial carcinoma.